The Bacterial Sepsis drugs in development market research report provides comprehensive information on the therapeutics under development for Bacterial Sepsis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Bacterial Sepsis. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Bacterial Sepsis and features dormant and discontinued products.
GlobalData tracks 13 drugs in development for Bacterial Sepsis by 12 companies/universities/institutes. The top development phase for Bacterial Sepsis is preclinical with nine drugs in that stage. The Bacterial Sepsis pipeline has 11 drugs in development by companies and two by universities/ institutes. Some of the companies in the Bacterial Sepsis pipeline products market are: Acepre, Northern Therapeutics and Ra Pharmaceuticals.
The key targets in the Bacterial Sepsis pipeline products market include Toll Like Receptor 4 (hToll or CD284 or TLR4), Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2), and Peptidoglycan (Murein).
The key mechanisms of action in the Bacterial Sepsis pipeline product include Toll Like Receptor 4 (hToll or CD284 or TLR4) Antagonist with two drugs in Preclinical. The Bacterial Sepsis pipeline products include five routes of administration with the top ROA being Intravenous and five key molecule types in the Bacterial Sepsis pipeline products market including Small Molecule, and Synthetic Peptide.
Bacterial Sepsis overview
Infection caused by bacteria known as bacterial sepsis. Sepsis is an emergency condition when existing infections in the body are triggered or body’s extreme response to an infection. Sepsis can result in multi organ damage and septic shock. It is also referred to as blood poisoning and septicemia. Flu, chest pain, paleness or bluish grey coloration of skin, rashes, SOB, fever, change in pulse rate, confusion, extreme pain and discomfort are common symptoms. Triggered with lung infections pneumonia, catheter associated infections. Evaluated by CRP levels, CBP, Lactate levels, venous blood gases, MRI, CT scan are done. Antibiotics are primary line drugs for sepsis followed by corticosteroids, monoclonal antibodies, fluid transfusions in septic shock conditions.
For a complete picture of Bacterial Sepsis’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
